Effective volume of ropivacaine 0.75% through a catheter required for interscalene brachial plexus blockade. 2013

Catherine Vandepitte, and Philippe Gautier, and Daquan Xu, and Emine A Salviz, and Admir Hadzic
Department of Anesthesiology, Catholic University of Leuven, Leuven, Belgium.

BACKGROUND Ultrasound guidance during peripheral nerve blocks has allowed for reduction in dose and volume of local anesthetic required to accomplish successful blockade using multiple injections through a needle. The authors undertook this study to determine the minimal effective volume required to accomplish successful interscalene brachial plexus block (ISB) through the catheter. METHODS After obtaining institutional ethics committee approval and written informed consent, patients aged 18-75 yr and scheduled for arthroscopic shoulder surgery under ISB were enrolled. All patients using a step-up/step-down method and the starting dose of 15 ml of 0.75% ropivacaine received an ultrasound-guided ISB catheter. The injection volume was increased or decreased by 1 ml in case of block failure or block success, respectively. RESULTS The authors found that the proportion of patients with successful blockade increased sharply from approximately 57% at 6 ml to 100% by 7 ml, indicating that a small increase in volume of ropivacaine 0.75% markedly affects the success rate. A total of 12 ISB with injection volume less than 7 ml resulted in successful anesthesia within 30 min, yielding an ED95 of 7 ml (95% CI 6.8-7.2) ropivacaine 0.75%. For the group as a whole, the median (min-max) sensory block onset time was 5 (5-20) min, the median (min-max) motor blocks for the biceps and the deltoid muscles were 7.5 (5-15) min and 10 (5-15) min, respectively. The median (min-max) block duration was 8.9 (3-15) h. CONCLUSIONS An injection of a minimum of 7 ml of ropivacaine 0.75% through the catheter is required for success rate and timely onset of surgical anesthesia with ISB.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009407 Nerve Block Interruption of NEURAL CONDUCTION in peripheral nerves or nerve trunks by the injection of a local anesthetic agent (e.g., LIDOCAINE; PHENOL; BOTULINUM TOXINS) to manage or treat pain. Chemical Neurolysis,Chemodenervation,Nerve Blockade,Block, Nerve,Blockade, Nerve,Blockades, Nerve,Blocks, Nerve,Chemical Neurolyses,Chemodenervations,Nerve Blockades,Nerve Blocks,Neurolyses, Chemical,Neurolysis, Chemical
D001917 Brachial Plexus The large network of nerve fibers which distributes the innervation of the upper extremity. The brachial plexus extends from the neck into the axilla. In humans, the nerves of the plexus usually originate from the lower cervical and the first thoracic spinal cord segments (C5-C8 and T1), but variations are not uncommon. Plexus, Brachial
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077212 Ropivacaine An anilide used as a long-acting local anesthetic. It has a differential blocking effect on sensory and motor neurons. 1-Propyl-2',6'-pipecoloxylidide,AL 381,AL-381,LEA 103,LEA-103,Naropeine,Naropin,Ropivacaine Hydrochloride,Ropivacaine Monohydrochloride,Ropivacaine Monohydrochloride, (S)-isomer,1 Propyl 2',6' pipecoloxylidide,AL381,LEA103
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Catherine Vandepitte, and Philippe Gautier, and Daquan Xu, and Emine A Salviz, and Admir Hadzic
July 2009, Veterinary anaesthesia and analgesia,
Catherine Vandepitte, and Philippe Gautier, and Daquan Xu, and Emine A Salviz, and Admir Hadzic
December 1998, Anesthesia and analgesia,
Catherine Vandepitte, and Philippe Gautier, and Daquan Xu, and Emine A Salviz, and Admir Hadzic
December 2020, Cureus,
Catherine Vandepitte, and Philippe Gautier, and Daquan Xu, and Emine A Salviz, and Admir Hadzic
November 1999, European journal of anaesthesiology,
Catherine Vandepitte, and Philippe Gautier, and Daquan Xu, and Emine A Salviz, and Admir Hadzic
December 1999, British journal of anaesthesia,
Catherine Vandepitte, and Philippe Gautier, and Daquan Xu, and Emine A Salviz, and Admir Hadzic
January 2001, European journal of anaesthesiology,
Catherine Vandepitte, and Philippe Gautier, and Daquan Xu, and Emine A Salviz, and Admir Hadzic
August 2002, Acta anaesthesiologica Scandinavica,
Catherine Vandepitte, and Philippe Gautier, and Daquan Xu, and Emine A Salviz, and Admir Hadzic
April 2001, Anesthesia and analgesia,
Catherine Vandepitte, and Philippe Gautier, and Daquan Xu, and Emine A Salviz, and Admir Hadzic
January 1999, Regional anesthesia and pain medicine,
Catherine Vandepitte, and Philippe Gautier, and Daquan Xu, and Emine A Salviz, and Admir Hadzic
January 2007, Regional anesthesia and pain medicine,
Copied contents to your clipboard!